Posts Tagged: therapy
Monica Nava and her 1-year-old daughter Clementine, who suffers from the "bubble baby" affliction. (Family photo).
The story about Jakob, Sheersha and Clementine is a 6,000-mile biomedical tale that spans the Atlantic. The story ranges from the Saskatchewan River in Canada to the dusty Tehachapi mountains in drought-plagued Southern California. And it is a story of children with a terrible and rare genetic affliction known as the bubble baby disease.
A scientist at work in a biomedical laboratory. (Photo: Tom Robertson, via Shutterstock)
The California stem cell agency says it is doing “everything” it can to move forward on a gene therapy that has saved the lives of more than 50 persons but which has been pushed aside by the company that has exclusive rights to it. The issue has raised questions about the ethics of withholding care from babies and children suffering from a fatal disease.
Hospital medical staff checking a patient's records. (Photo: Stokkete, via Shutterstock)
OPINION: It’s never a good idea when insurers cut costs by interfering in the decision-making process between patients and their doctor. But during a national pandemic, it’s a particularly bad idea. I am thinking specifically of an insurance strategy called step therapy.
Students attending a lecture. (Photo: sirtravelalot, via Shutterstock)
Stressed by classes, grades, jobs, personal issues and COVID-19, some California community college students are turning to mental health counseling. But the service is scarce and demand is high. One major study found that community college students reported higher rates of academic impairment due to mental health struggles than students attending than students at the University of California or California State University.
Stem cell research using what's known as a PCR strip. (Image: Science Photo via Shutterstock)
Backers of a California ballot initiative to provide $5.5 billion more for the state’s cash-strapped stem cell agency say they will take their first official step by the end of this month.That’s when they will submit the proposed measure to California election officials and trigger a many-months-long process. The effort is aimed at ensuring that the nearly 15-year-old research effort survives in a meaningful way beyond next year.
A stem cell researcher at work. (Photo: 18percentgrey, via Shutterstock)
The California stem cell agency handed out $16.4 million in research grants seeking therapies for afflictions ranging from gum disease and cancer to vision loss and Parkinson’s Disease. The award for Parkinson’s was relatively tiny — only $150,000 — but represented a rare case in which the agency’s governing board overturned its reviewers, who make the de facto decisions on awards
A human DNA complex. ((Illustration, Shutterstock)
The man often called the father of the California stem cell agency has all but said he is set to launch an effort to pump an additional $5 billion in state funding into the research effort, which is scheduled to run out of cash in about three years.
A health care professional tallies the cost of a patient's care. (Photo: Monika Wisniewska)
Not long ago, I had dinner with a group of friends from college. One of the big topics of conversation was Medicare, for which we’ll all be eligible in the next several years. (Farewell, callow youth!) And one of the biggest questions about Medicare was, “How much is it going to cost me?” Like private health insurance, Medicare has premiums, deductibles, and co-pays. These costs can – and often do – change from year to year. What you actually pay depends on your work history, income, and inflation.
Throat cancer patient Karl Trede, who was treated with the "eat me" protein therapy. (Photo: California Institute for Regenerative Medicine)
In an emotion-choked session, the mother of a six-year-old girl thanked California’s stem cell agency for saving the life of her daughter. “Thank you for keeping my family complete,” said Alysia Padilla-Vaccaro, her voice cracking as she spoke to the governing board of the $3 billion California Institute for Regenerative Medicine (CIRM), as the agency is formally known.
A research scientist on the job in a laboratory. (Photo: Anyaivanova, via Shutterstock
After a hiccup last month, the California stem cell agency this week coughed up $15 million for a quartet of researchers looking into Alzheimer’s disease, cartilage repair, arthritis and sickle cell disease, but not before lopping off a big chunk of one proposal.